查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球过敏治疗市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按类型、按治疗方法、按给药途径、按分销渠道、按地区划分
市场调查报告书
商品编码
1289640

全球过敏治疗市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按类型、按治疗方法、按给药途径、按分销渠道、按地区划分

Global Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Treatment, By Route of Administration, By Distribution channel, By Region
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球过敏治疗市场预计将在2023-2027年预测期内见证稳定的复合年增长率。这可以归因于全球各地人口中不同种类的过敏症日益普遍的情况。根据食物过敏研究和教育组织在2020年发表的一份报告，估计美国约有3200万居民有食物过敏。此外，非处方药的使用越来越多，以及自我治疗的日益普及，预计将进一步为全球过敏治疗市场的增长创造有利可图的机会。此外，用于治疗不同过敏症的免疫疗法日益普及，预计将进一步支持市场增长。此外，全球各地不断增长的老年人口预计将增加对不同过敏治疗的需求。老年人口的免疫系统较弱，更容易受到不同种类过敏的影响，从而增加了对治疗各种过敏的不同治疗方案的需求。

污染水平的上升

室内和室外污染的增加导致哮喘和呼吸道不同的过敏性疾病的患病率增加。在2019年，美国约有7.8%的人口患有哮喘病。这反过来又会刺激到2027年的市场增长。此外，空气污染会加重过敏性鼻炎的症状，如头痛、鼻塞或流鼻涕、眼睛发痒或流泪，以及睡眠障碍。另外，研究表明，由于室内和室外空气中存在不同的污染物，会造成不同的眼睛过敏。这反过来又会增加对专门针对污染引起的过敏的治疗的需求。

治疗过敏的免疫疗法的发展

革新过敏治疗市场的主要趋势之一是不同类型的免疫疗法的发展。各种生物技术和制药公司，以及全球各地不同的学术和研究机构正在投资于研发活动，以开发用于治疗不同过敏症的免疫疗法。例如，Aimmune Therapeutics, Inc.正在开发一种研究性生物免疫疗法药物AR101，用于治疗花生过敏症。根据clinicaltrials.gov的数据，截至2022年9月，全球约有364项过敏免疫疗法研究处于不同的发展阶段。这反过来预计将为全球过敏治疗市场的增长创造有利可图的机会。

可用的定制服务

利用给定的市场数据，TechSci Research根据公司的具体需求提供定制服务。该报告有以下定制选项：

公司信息

  • 其他市场参与者（最多5家）的详细分析和概况。

目录

第一章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19对全球过敏治疗市场的影响

第五章：客户的声音

第六章：全球过敏症治疗市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额和预测
    • 按类型（眼睛过敏、食物过敏、皮肤过敏、哮喘、鼻炎、其他）分类
    • 按治疗方法（抗过敏药物和/或免疫疗法）分类
    • 按给药途径（口服、吸入剂、鼻腔内、其他）
    • 按销售渠道（医院药店、零售药店、网上药店）分类
    • 按地区分类
    • 按公司分类(2021年)
  • 市场地图

第七章：北美过敏治疗市场展望

  • 市场规模和预测
    • 按价值分类
  • 市场份额和预测
    • 按类型
    • 按治疗方法分类
    • 按给药途径分类
    • 按销售渠道分类
    • 按国家分类
  • 北美洲：国家分析
    • 美国
    • 美国
    • 墨西哥

第8章：欧洲过敏治疗市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额与预测
    • 按类型
    • 按治疗方法分类
    • 按给药途径分类
    • 按销售渠道分类
    • 按国家分类
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第九章：亚太地区过敏治疗市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型
    • 按治疗方法分类
    • 按给药途径分类
    • 按销售渠道分类
    • 按国家分类
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第十章：南美的过敏治疗市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额与预测
    • 按类型
    • 按治疗方法分类
    • 按给药途径分类
    • 按销售渠道分类
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 ：中东和非洲的过敏治疗市场前景

  • 市场规模和预测
    • 按价值
  • 市场份额和预测
    • 按类型
    • 按治疗方法分类
    • 按给药途径分类
    • 按销售渠道分类
    • 按国家分类
  • MEA: 国家分析
    • 南非 过敏症治疗
    • 沙特阿拉伯 过敏症治疗
    • 阿拉伯联合酋长国过敏治疗

第十二章 ：市场动态

  • 驱动力
  • 挑战

第十三章 ：市场趋势与发展

第十四章：竞争格局

  • 强生公司 Sanofi SA GlaxoSmithKline plc.F. Hoffmann-La Roche AG Leti Pharma GmbH AbbVie Inc.Alembic Pharmaceuticals Limited Bausch Health Companies Inc.Novartis AG ALK-Abello AS

第十五章：战略建议

简介目录
Product Code: 13036

The global allergy treatment market is anticipated to witness a growth of steady CAGR in the forecast period, 2023-2027. This can be ascribed to the growing prevalence of different kinds of allergies among populations across the globe. According to a report published by Food Allergy Research & Education in 2020, estimated that around 32 million residents in the United States have food allergies. Additionally, the growing use of over-the-counter medications and the increasing popularity of self-medication is further expected to create lucrative opportunities for the growth of global allergy treatment market. Besides, the growing popularity of immunotherapy for the treatment of different allergies is further expected to support market growth. Furthermore, the growing geriatric population across the globe is expected to increase the demand for different allergy treatments. The elderly population has a weaker immune system and is more susceptible to different kinds of allergies, thereby increasing the demand for different treatment options for the treatment of various allergies.

Rising Pollution Levels

Increasing indoor and outdoor pollution is leading to an increase in the prevalence of asthma and different allergic disorders of the respiratory tract. In 2019, around 7.8% population in the United States had asthma. This, in turn, is expected to spur the market growth through 2027. Additionally, air pollution can aggravate the symptoms of allergic rhinitides, such as headaches, blocked or runny noses, itchy or watery eyes, and sleep disturbances. Also, studies suggest that different eye allergies can be caused due to presence of different pollutants in indoor and outdoor air. This, in turn, is expected to increase the demand for treatments specific to the allergies caused due to pollution.

Development of Immunotherapies for the Treatment of Allergies

One of the key trends revolutionizing the allergy treatment market is the development of different types of immunotherapies. Various biotechnology & pharmaceutical companies, along with different academic & research institutions across the globe are investing in research & development activities for developing immunotherapies for the treatment of different allergies. For instance, Aimmune Therapeutics, Inc. is developing an investigational biologic immunotherapy drug, AR101, for the treatment of peanut allergy. According, to clinicaltrials.gov, as of September 2022, there are around 364 allergy immunotherapy studies under different phases of development worldwide. This, in turn, is expected to create lucrative opportunities for the growth of global allergy treatment market.

Market Segmentation

Global Allergy Treatment market can be segmented by type, treatment, route of administration, distribution channel, by region. Based on type, the market can be segmented into eye allergy, food allergy, skin allergy, asthma, rhinitis, and others. Based on treatment, the market can be divided into anti-allergy medications and immunotherapy. Based on the route of administration, the market can be differentiated into oral, inhalers, intranasal, and others. Based on distribution channels, the market can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. The United States dominates the global allergy treatment market among different countries. This can be ascribed to the growing prevalence of different types of allergies in Americans. A survey conducted in the United States in 2021 stated that around 44% of adults in the United States suffered from pollen allergies, while 15% of the population reported drug allergies.

Market Players

Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Leti Pharma GmbH, AbbVie Inc., Alembic Pharmaceuticals Limited, Bausch Health Companies Inc., Novartis AG, ALK-Abello AS are some of the leading players operating in the Global Allergy Treatment Market.

Report Scope

In this report, Global Allergy Treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Allergy Treatment Market, By Type:

  • Eye Allergy
  • Food Allergy
  • Skin Allergy
  • Asthma
  • Rhinitis
  • Others

Allergy Treatment Market, By Treatment:

  • Anti-Allergy Medications
  • Immunotherapy

Allergy Treatment Market, By Route of Administration:

  • Oral
  • Inhalers
  • Intranasal
  • Others

Allergy Treatment Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Allergy Treatment Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Allergy Treatment Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Allergy Treatment Market

5. Voice of Customer

6. Global Allergy Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, Others)
    • 6.2.2. By Treatment (Anti-Allergy Medications v/s Immunotherapy)
    • 6.2.3. By Route of Administration (Oral, Inhalers, Intranasal, Others)
    • 6.2.4. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 6.2.5. By Region
    • 6.2.6. By Company (2021)
  • 6.3. Market Map

7. North America Allergy Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Treatment
    • 7.2.3. By Route of Administration
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Allergy Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Treatment
        • 7.3.1.2.3. By Route of Administration
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Canada Allergy Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Treatment
        • 7.3.2.2.3. By Route of Administration
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. Mexico Allergy Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Treatment
        • 7.3.3.2.3. By Route of Administration
        • 7.3.3.2.4. By Distribution Channel

8. Europe Allergy Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Treatment
    • 8.2.3. By Route of Administration
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Allergy Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Treatment
        • 8.3.1.2.3. By Route of Administration
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. Germany Allergy Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Treatment
        • 8.3.2.2.3. By Route of Administration
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. United Kingdom Allergy Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Treatment
        • 8.3.3.2.3. By Route of Administration
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Italy Allergy Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Treatment
        • 8.3.4.2.3. By Route of Administration
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Spain Allergy Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Treatment
        • 8.3.5.2.3. By Route of Administration
        • 8.3.5.2.4. By Distribution Channel

9. Asia-Pacific Allergy Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Treatment
    • 9.2.3. By Route of Administration
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Allergy Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Treatment
        • 9.3.1.2.3. By Route of Administration
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. India Allergy Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Treatment
        • 9.3.2.2.3. By Route of Administration
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Japan Allergy Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Treatment
        • 9.3.3.2.3. By Route of Administration
        • 9.3.3.2.4. By Distribution Channel
    • 9.3.4. South Korea Allergy Treatment Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Treatment
        • 9.3.4.2.3. By Route of Administration
        • 9.3.4.2.4. By Distribution Channel
    • 9.3.5. Australia Allergy Treatment Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Treatment
        • 9.3.5.2.3. By Route of Administration
        • 9.3.5.2.4. By Distribution Channel

10. South America Allergy Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Treatment
    • 10.2.3. By Route of Administration
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Allergy Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Treatment
        • 10.3.1.2.3. By Route of Administration
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Argentina Allergy Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Treatment
        • 10.3.2.2.3. By Route of Administration
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. Colombia Allergy Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Treatment
        • 10.3.3.2.3. By Route of Administration
        • 10.3.3.2.4. By Distribution Channel

11. Middle East and Africa Allergy Treatment Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Treatment
    • 11.2.3. By Route of Administration
    • 11.2.4. By Distribution Channel
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Allergy Treatment Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Treatment
        • 11.3.1.2.3. By Route of Administration
        • 11.3.1.2.4. By Distribution Channel
    • 11.3.2. Saudi Arabia Allergy Treatment Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Treatment
        • 11.3.2.2.3. By Route of Administration
        • 11.3.2.2.4. By Distribution Channel
    • 11.3.3. UAE Allergy Treatment Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Treatment
        • 11.3.3.2.3. By Route of Administration
        • 11.3.3.2.4. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Johnson & Johnson
  • 14.2. Sanofi SA
  • 14.3. GlaxoSmithKline plc.
  • 14.4. F. Hoffmann-La Roche AG
  • 14.5. Leti Pharma GmbH
  • 14.6. AbbVie Inc.
  • 14.7. Alembic Pharmaceuticals Limited
  • 14.8. Bausch Health Companies Inc.
  • 14.9. Novartis AG
  • 14.10. ALK-Abello AS

15. Strategic Recommendations